chevron_leftBack
As of 24 June 2026, SANUWAVE Health, Inc. has a market cap of $70.51M USD, ranking #28033 globally and #4239 in the United States.
It ranks #2528 in the Healthcare sector, and #517 in the Medical Devices industry.
Key Stats
Market Cap
$70.51MUSD
Enterprise Value
$158.4MUSD
Revenue (TTM)
$44.05MUSD
EBITDA (TTM)
$7.49MUSD
Net Income (TTM)
$11.81MUSD
EBITDA Margin
17%
Profit Margin
27%
PE Ratio
40.7
Forward PE
43.2
PS Ratio
3.3
PB Ratio
97.7
EV/EBITDA
21.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Morgan Frank
open_in_new
Employees
55
Founded
2004
Website
sanuwave.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -9.7% | -13% | -9.7% | -36% | -46% | -39% |
News
Loading...
SNWV Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SNWV
SANUWAVE Health Inc
ISIN: US80303D3052
Shares Out.:
Shares Outstanding:
8.599M1
Shares Float:
8.133M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
16.62 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
246K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
228K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
225K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
179K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
171K%
|
38.3
|
|
NYSE: BSX
|
$84.93B
120K%
|
24.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: MDT
|
$101.9B
144K%
|
22.2
|
|
EPA: EL
|
$96.33B
137K%
84.32B EUR
|
36.7
|
|
TSE: 7741
|
$60.9B
86K%
9.83T JPY
|
40.0
|
|
XETRA: SHL
|
$44.95B
64K%
39.34B EUR
|
18.7
|
|
SIX: ALC
|
$35.83B
51K%
28.99B CHF
|
37.9
|
|
|
$30.06B
43K%
203.66B CNY
|
26.0
|
chevron_leftBack